All Things CLL With Nitin Jain
Healthcare Unfiltered
00:00
Why Karambezel Remains a Comparator Arm for CLL
Karambezel lubintu zumab was considered an appropriate regimen for patients with CLL in 2014 2015. In today's world if I'm designing thing to trial today I would say absolutely no it should not be the case. We're still learning about the duration of the combination therapy so once you have these kind of things you have to go back and see what was the standard at that time when that trial was designed.
Transcript
Play full episode
